Transaction · 0001674236-26-000008

CAREY STEPHEN P.

CAREY STEPHEN P., SVP, CFO, reported an open-market or private sale at ANI PHARMACEUTICALS INC involving 4000.000000 shares for an estimated $302240.00. Reported holdings after the transaction were 185543.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market sellSEC transaction code SSVP, CFO
ANIPANI PHARMACEUTICALS INC
Filing timeMar 05
Trade dateMar 05, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$75.59
Pre-filing
1mo ago +5.7%1w ago +2.1%1d ago +1.2%
Returns since
7d -4.1%30d -1.8%90d -0.5%180d -2.8%1y -2.8%

ANIP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
ANIP since 2026-03-05Filed 182 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0001674236-26-000008
Common Stock
Transaction date
Mar 05, 2026
Filed Mar 05, 2026, 12:00 AM · 0d delay
Shares
4.00k sh
$7.55k per share
Estimated value
-$30.2M
Computed from shares × price
Holdings after
185k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller
+10score
Filing-only score

+10

Compact filing score computed from stored Form 4 facts. Version v1.

Positive filing signal

This filing has a modest positive filing-only score. Treat it as a useful flag for review, not as a buy signal.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

SVP & CFO

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The shares were sold in multiple trades at prices ranging from $75.41 to $75.56. The price reported above reflects the weighted average sales price.

  2. F2

    25% of the total options vested on each of March 31, 2018, March 31, 2019, March 31, 2020, and March 31, 2021.

Original filing · 0001674236-26-000008
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

ANIP